Attending SCOPE Summit 2025? We hope to see you there!
Don't miss the panel, "Integrating Diversity into Clinical Trial Feasibility & Site Engagement," moderated by Lauren Chazal, our Chief Business Development Officer at Headlands Research, on Tue Feb 4th at 4:55pm, to learn about the critical need of embedding Diversity, Equity, and Inclusion (DEI) into the fabric of feasibility studies, and delve into the transformative power of technology, data-driven methodologies, and collaborative frameworks in revolutionizing site engagement.
Also, catch the panel discussion, "What Sites Really Want from Study Sponsors and CROs," on Wed, Feb 5th, at 8:55am, to hear from representatives at leading sites, including Lauren Chazal, our Chief Business Development Officer at Headlands Research, about what their organizations really want from sponsors and CROs.
Schedule a time to chat with our experts on-site during the event to learn about how the Headlands Research network of sites is driving innovation in clinical trials with a focus on large-volume recruitment and retention of diverse, inclusive, and specialty populations and delivering the highest quality data.
Email a Headlands Research team member to schedule a meeting at SCOPE Summit:
- Kyle Burtnett, Chief Executive Officer
- Lauren Chazal, Chief Business Development Officer
- Chris Cugliari, Vice President of Corporate Development
- Michelle Sowell, Director of Vaccines
- Ryan Cady, Director of Metabolic and Endocrine Strategy
- Jordan Wertheimer, Director of Business Development
- McKenzie Lang, Director of Business Development
- Tori Wallenburg, Director of Business Development